Comparative study of neoadjuvant chemoradiotherapy, chemotherapy, and chemoimmunotherapy for locally advanced esophageal squamous cell carcinoma
NCIT may offer superior survival benefits over NCRT and NCT in patients with LAESCC, particularly when combined with adjuvant chemoimmunotherapy (ACIT). These findings underscore the potential of immunotherapy in multimodal treatment of LAESCC and warrant further investigation in prospective clinical trials.
Authors
- Junhong Liu (ORCID: https://orcid.org/0000-0001-9786-7601)
- Junfeng Liu (ORCID: https://orcid.org/0000-0001-9336-9146)
- Shuai Zhang (ORCID: https://orcid.org/0000-0002-5662-4758)
- Shuchai Zhu (ORCID: https://orcid.org/0000-0003-4418-7324)
- Rong Yu (ORCID: https://orcid.org/0009-0008-0816-9587)
- Lan Wang (ORCID: https://orcid.org/0000-0003-4304-2342)
- Likun Liu (ORCID: https://orcid.org/0000-0002-3861-3115)
- Yan Ding (ORCID: https://orcid.org/0000-0001-6391-1977)
- Weili Zhang
Institutions
- Hebei Medical University (CN)
- Fourth Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-08-16
- DOI
- https://doi.org/10.1186/s12885-025-14747-z
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Hebei Medical University